Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

University of Alabama at Birmingham at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

University of Alabama at Birmingham brings 48 presentations to ASH 2026 in New Orleans. Its program centres on leukemia, sickle cell disease and the delivery of care, from laboratory biology to quality improvement. It covers topics such as outpatient CAR T-cell therapy and the leukemia microenvironment in central nervous system disease.

OrganizationASH 2026 Attendance
Universities & research institutes
Public research university and academic medical center in Birmingham, Alabama.
Symposium
Fri Dec 11
11:00am–2:00pm
Show Me the Data™: Emerging Evidence and Evolving Clinical Practice in Essential Thrombocythemia and Polycythemia Vera
Newer options for polycythemia vera and essential thrombocythemia, such as ropeginterferon and rusfertide, and what to do when hydroxyurea fails.
Leukemias
Symposium
Fri Dec 11
11:00am–2:00pm
The CELMoD Shift: Translating Protein Degradation Science into Practice-Changing Myeloma Care
Cereblon-modulating protein degraders for relapsed myeloma, from biology and trial data to sequencing, neutropenia management, and residual disease testing.
Myeloma · New drugs
Session
Fri Dec 11
3:00pm–6:00pm
Scientific Workshop on New Frontiers in T-Cell Acute Lymphoblastic Leukemia Biology: Metabolism, Genomics, and Microenvironment
Gene regulation, metabolism and the surrounding tissue in T-cell acute lymphoblastic leukemia, studied with single-cell and spatial tools.
Leukemias
Session
Fri Dec 11
5:15pm–5:55pm
Leukemia-Microenvironment Interactions and CNS Disease
How surroundings, inflammation and stress shape T-cell leukemia progression and treatment response, including disease in the brain and spinal cord.
Leukemias
Talk
Sun Dec 13
4:30pm–5:45pm
Showcasing ASH Resources for Continuing Medical Education for Local and International Trainees and Practitioners
Digital learning, clinical guidelines, and visiting-trainee mentorship programs that expand hematology training worldwide and build lasting local expertise.
Patient care
Session
Mon Dec 14
12:15pm–1:15pm
ASH Poster Walk on Leukemia in Latin America: Outcomes and Access to Diagnostics and Therapies Hosted by Blood Global Hematology
How access to diagnosis, molecular testing, new drugs, transplant and trials shapes leukemia outcomes across Latin America.
Leukemias · Patient care
Session
Mon Dec 14
1:15pm–1:30pm
Meet the Journal Editors: Blood Global Hematology
Meet editors of the society's international open-access journal on hematology problems of global impact, including local guidelines and public health.
Talk
Mon Dec 14
2:45pm–4:00pm
After the Fall: Trial Design, National and International, in the Modern Era of Sickle Cell Disease
Why sickle cell disease trials have struggled, and how more objective endpoints could let more patients enroll and speed new therapies.
Red cells

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Alabama at Birmingham

Tell us what you sell and we’ll find the people at University of Alabama at Birmingham most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction